Hero MotoCorp (NSE: HEROMOTOCO) May dispatches rise to 5.7 lakh units as VIDA and exports sharpen growth story
Read More Pharma Industry News Moderna (MRNA) and Merck (MRK) cancer vaccine sustains benefit at five years, but investors stay cautious Moderna and Merck's mRNA cancer vaccine sustained a 49% reduction in melanoma recurrence at five years, but MRNA fell as investors weigh near-term pressures. byPallavi MadhirajuJune 2, 2026